2,6-bis-(aminomethyl)piperidine derivatives

US9695121B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9695121-B2
Application numberUS-201414764010-A
CountryUS
Kind codeB2
Filing dateJan 27, 2014
Priority dateJan 30, 2013
Publication dateJul 4, 2017
Grant dateJul 4, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to 2,6-bis(aminomethyl)piperidine derivatives as such (in the following text abbreviated to “2,6-BAMP derivatives”) which are defined by the general formula (I) shown in the following text. In addition, the present invention relates to a process for preparing such 2,6-BAMP derivatives by hydrogenation of the corresponding 2,6-dicyanopiperidine derivatives (hereinafter abbreviated to “2,6-DCP derivatives”) in the presence of a catalyst. The present invention further provides for the use of the 2,6-BAMP derivatives of the invention as hardeners for epoxy resins, as intermediate in the preparation of diisocyanates, which play an important role in the production of polyurethanes, as starters in the preparation of polyetherols and/or as monomers for polyamide production. The present invention further relates to the diisocyanates as such prepared from the 2,6-BAMP derivatives and also the corresponding preparative process.

First claim

Opening claim text (preview).

The invention claimed is: 1. A 2,6-bis(aminomethyl)piperidine derivative (2,6-BAMP derivative) of the general formula (I), where: A, B and D are each, independently of one another, CH 2 , CHR 2 or CR 2 R 3 ; R 1 is unsubstituted or at least monosubstituted C 1 -C 30 -alkyl, unsubstituted or at least monosubstituted C 2 -C 10 -alkenyl or unsubstituted or at least monosubstituted aryl, where the substituents are selected from the group consisting of C 1 -C 4 -alkyl, aryl 2 , —OR 4 , —C(O)R 6 , —C(O)OR 4 , —O—C(O)R 6 , —NR 4 R 5 or halogen, and aryl 2 can in turn be at least monosubstituted by C 1 -C 4 -alkyl, —OR 4 , —C(O)R 6 , —C(O)OR 4 , —O—C(O)R 6 , —NR 4 R 5 or halogen; R 2 and R 3 are each, independently of one another, unsubstituted or at least monosubstituted C 1 -C 10 -alkyl or unsubstituted or at least monosubstituted aryl, where the substituents are selected from the group consisting of C 1 -C 4 -alkyl, —OR 4 , —C(O)OR 4 , —O—C(O)R 6 , —NR 4 R 5 or halogen; R 4 and R 5 are each, independently of one another, hydrogen or unsubstituted C 1 -C 4 -alkyl; R 6 is unsubstituted C 1 -C 10 -alkyl. 2. The 2,6-BAMP derivative according to claim 1 , wherein the 2,6-BAMP derivative is defined according to the general formula (la), where: R 1 is unsubstituted or at least monosubstituted C 1 -C 10 -alkyl, unsubstituted or at least monosubstituted C 2 -C 10 -alkenyl or unsubstituted or at least monosubstituted aryl, where the substituents are selected from the group consisting of C 1 -C 4 -alkyl, aryl 2 , —OR 4 , —NR 4 R 5 or halogen, and aryl 2 can in turn be at least monosubstituted by C 1 -C 4 -alkyl, —OR 4 , —NR 4 R 5 or halogen; and R 4 and R 5 are each, independently of one another, hydrogen or unsubstituted C 1 -C 4 -alkyl. 3. The 2,6-BAMP derivative according to claim 1 , wherein: R 1 is unsubstituted or at least monosubstituted C 1 -C 4 -alkyl and the substituent is —NR 4 R 5 ; and R 4 and R 5 are each, independently of one another, hydrogen or unsubstituted C 1 -C 4 -alkyl. 4. A process for preparing a 2,6-bis-aminomethyl)piperidine derivative, a 2,6-BAMP-derivative, according to the general formula (I) wherein the 2,6-BAIMP-derivative is obtained from the corresponding 2,6-dicyanopiperidine derivative, the 2,6-DCP-derivative, of the general formula (II) or (IIa) by hydrogenation in the presence of a catalyst, wherein A, B and D are each, independently of one another, CH 2 , CHR 2 or CR 2 R 3 ; R 1 is unsubstituted or at least monosubstituted C 1 C 30 -alkyl, unsubstituted or at least monosubstituted C 2 -C 10 -alkenyl or unsubstituted or at least monosubstituted aryl, where the substituents are selected from the group consisting of C 1 -C 4 -alkyl, aryl 2 , —OR 4 , —C(O)R 6 , —C(O)OR 4 , —O—C(O)R 6 , —NR 4 R 5 or halogen, and aryl 2 can in turn be at least monosubstituted by C 1 -C 4 alkyl, —OR 4 , —C(O)R 6 , —C(O)R 4 , —O—C(O)R 6 , —NR 4 R 5 or halogen; R 2 and R 3 are each, independently of one another, unsubstituted or at least monosubstituted C 1 -C 10 -alkyl or unsubstituted or at least monosubstituted aryl, where the substituents are selected from the group consisting of C 1 -C 4 -alkyl, —OR 4 —C(O)R 6 , —C(O)OR 4 , —O—C(O)R 6 , —NR 4 R 5 or halogen; R 4 and R 5 are each, independently of one another, hydrogen or unsubstituted C 1 -C 4 -alkyl; and R 6 is unsubstituted C 1 -C 10 -alkyl. 5. The process according to claim 4 , wherein a Raney catalyst, preferably a Raney nickel catalyst or a Raney cobalt catalyst, in particular a Raney cobalt catalyst, which comprises at least one of the elements Fe, Ni or Cr as promoter is used as catalyst. 6. The process according to claim 4 , wherein the hydrogenation is carried out in a solvent which is an amide, an aromatic hydrocarbon, an alcohol, an amine, an ester or an ether. 7. The process according to claim 4 , wherein the hydrogenation is carried out at a pressure from 80 to 200 bar or at a temperature from 90 to 130° C. 8. The process according to claim 4 , wherein the 2,6-DCP derivative used for the hydrogenation is prepared by reaction of i) glutaraldehyde or a glutaraldehyde derivative with ii) hydrogen cyanide (HCN) and iii) an appropriate amine of the formula R 1 NH 2 . 9. A method comprising a step, wherein a 2,6-BAMP derivative according to the definition of the general formula (I) in claim 4 is employed as hardener for epoxy resins. 10. A diisocyanate of the general formula (III), where: A, B and D are each, independently of one another, CH 2 , CHR 2 or CR 2 R 3 ; R 1 is hydrogen, unsubstituted or at least monosubstituted C 1 -C 30 -alkyl, unsubstituted or at least monosubstituted C 2 -C 10 -alkenyl or unsubstituted or at least monosubstituted aryl, where the substituents are selected from the group consisting of C 1 -C 4 -alkyl,aryl 2 , —OR 4 , —C(O)R 6 , —C(O)OR 4 , —O—C(O)R 6 , —NR 4 R 5 or halogen, and aryl 2 can in turn be at least monosubstituted by C 1 -C 4 -alkyl, —OR 4 , —C(O)R 6 , —C(O)OR 4 , —O—C(O)R 6 , —NR 4 R 5 or halogen; R 2 and R 3 are each, independently of one another, unsubstituted or at least monosubstituted C 1 -C 10 -alkyl or unsubstituted or at least monosubstituted aryl, where the substituents are selected from the group consisting of C 1 -C 4 alkyl, —OR 4 —C(O)R 6 , —C(O)OR 4 , —O—C(O)R 6 , —NR 4 R 5 or halogen; R 4 and R 5 are each, independently of one another, hydrogen or unsubstituted C 1 -C 4 -alkyl; and R 6 is unsubstituted C 1 -C 10 -alkyl. 11. The diisocyanate according to claim 10 , wherein the diisocyanate is defined according to the general formula (IIIa), where: R 1 is hydrogen, unsubstituted or at least monosubstituted C 1 -C 10 -alkyl or unsubstituted or at least monosubstituted aryl, where the substituents are selected from the group consisting of C 1 -C 4 -alkyl, aryl 2 , —OR 4 , —NR 4 R 5 or halogen, and aryl 2 can in turn be at least monosubstituted by C 1 -C 4 -alkyl, —OR 4 , —NR 4 R 5 or halogen; R 4 and R 5 are each, independently of one another, hydrogen or unsubstituted C 1 -C 4 -alkyl. 12. A process for preparing a diisocyanate according to claim 10 , wherein a 2,6-BAMP derivative according to the definition of the general formula (II) in claim 4 is reacted with phosgene. 13. A method comprising a step, wherein a 2,6-BAMP derivative according to the definition of the general formula (I) in claim 4 is employed as intermediate in the preparation of diisocyanates. 14. A method comprising a step, wherein a 2,6-BAMP derivative according to the definition of the general formula (I) in claim 4 is employed as starter in the preparation of polyetherol or as monomer for polyamide production. 15. The process according to claim 4 , wherein the hydrogenation is carried out at a pressure from 80 to 200 bar and

Assignees

Inventors

Classifications

  • Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title

  • C07D211/26Primary

    with hydrocarbon radicals, substituted by nitrogen atoms · CPC title

  • containing at least two isocyanate groups bound to the same carbon skeleton · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9695121B2 cover?
The present invention relates to 2,6-bis(aminomethyl)piperidine derivatives as such (in the following text abbreviated to “2,6-BAMP derivatives”) which are defined by the general formula (I) shown in the following text. In addition, the present invention relates to a process for preparing such 2,6-BAMP derivatives by hydrogenation of the corresponding 2,6-dicyanopiperidine derivatives (hereinaf…
Who is the assignee on this patent?
Basf Se
What technology area does this patent fall under?
Primary CPC classification C07D211/26. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).